KF21213 is primarily utilized in the field of pharmaceutical research as a potential therapeutic agent. It is being studied for its efficacy in targeting specific cellular pathways, particularly in the treatment of inflammatory diseases and certain types of cancers. Its mechanism of action involves modulating key enzymes or receptors that play a role in disease progression. Researchers are also exploring its potential as a component in drug formulations to enhance bioavailability and stability. Additionally, KF21213 is being investigated for its role in combination therapies, where it may amplify the effects of other drugs, offering a more comprehensive treatment approach. Its application extends to preclinical studies, where it aids in understanding disease mechanisms and evaluating safety profiles.